The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice
Open accessAbstract
Background: Dietary intake of fruit and vegetables is associated with lower incidence of hypertension, but the mechanisms involved have not been elucidated. Here, we evaluated the effect of a high-fiber diet and supplementation with the short-chain fatty acid acetate on the gut microbiota and the prevention of cardiovascular disease. Methods: Gut microbiome, cardiorenal structure/function, and blood pressure were examined in sham and mineralocorticoid excess–treated mice with a control diet, high-fiber diet, or acetate supplementation. We also determined the renal and cardiac transcriptome of mice treated with the different diets. Results: We found that high consumption of fiber modified the gut microbiota populations and increased the abundance of acetate-producing bacteria independently of mineralocorticoid excess. Both fiber and acetate decreased gut dysbiosis, measured by the ratio of Firmicutes to Bacteroidetes, and increased the prevalence of Bacteroides acidifaciens . Compared with mineralocorticoid-excess mice fed a control diet, both high-fiber diet and acetate supplementation significantly reduced systolic and diastolic blood pressures, cardiac fibrosis, and left ventricular hypertrophy. Acetate had similar effects and markedly reduced renal fibrosis. Transcriptome analyses showed that the protective effects of high fiber and acetate were accompanied by the downregulation of cardiac and renal Egr1 , a master cardiovascular regulator involved in cardiac hypertrophy, cardiorenal fibrosis, and inflammation. We also observed the upregulation of a network of genes involved in circadian rhythm in both tissues and downregulation of the renin-angiotensin system in the kidney and mitogen-activated protein kinase signaling in the heart. Conclusions: A diet high in fiber led to changes in the gut microbiota that played a protective role in the development of cardiovascular disease. The favorable effects of fiber may be explained by the generation and distribution of one of the main metabolites of the gut microbiota, the short-chain fatty acid acetate. Acetate effected several molecular changes associated with improved cardiovascular health and function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One example includes a recent rodent hypertension study in which either a high-fiber diet (a prebiotic) or acetic acid alone (a gut microbial product) resulted in reduced blood pressure and adverse cardiac remodeling168.”
From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [168]
In the citing paper
“A significant proportion of the SCFAs produced in the distal bowel is reabsorbed from the gut lumen by facilitated apical solute transport via multiple different transporters114–117 as well as via passive (concentration-dependent) diffusion118.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [118]
In the citing paper
“Finally, studies in animal models and in patients with hypertension have reported that interventions that target the gut microbiota, such as a high-fibre diet, probiotics and antibiotics, have blood-pressure lowering effects87,92–99.”
From The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease (2018) · cites this paper as [95]
In the citing paper
“In DOCA-salt hypertensive mice, a high-fibre diet led to substantial reductions in both SBP and DBP (~20 mmHg)95.”
From The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease (2018) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedSubramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure
Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., Bray, G. A., Vogt, T. M., Cutler, J. A., Windhauser, M. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361601 · Cited by 5,981
PEAR: a fast and accurate Illumina Paired-End reAd mergeR
Zhang, J., Kobert, K., Flouri, T., & Stamatakis, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt593 · Cited by 4,497
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., et al. (2009) · Nature · doi:10.1038/nature08530 · Cited by 3,241
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1038/mi.2016.1042 · DOI
Cited by
Sorted by citations
Items 401–500 of 998
Kanmani, S., Son, T., Kim, K., & Koo, B. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104583 · Cited by 31
Obstructive Sleep Apnea as a Cardiovascular Risk Factor—Beyond CPAP
Bock, J. M., Vungarala, S., Karim, S., & Somers, V. K. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.01.027 · Cited by 30
The Gut Microbiota and Their Metabolites in Human Arterial Stiffness
Dinakis, E., Nakai, M. E., Gill, P. A., Yiallourou, S. R., Sata, Y., Muir, J. G., Carrington, M. J., Head, G. A., Kaye, D. M., & Marques, F. Z. (2021) · Heart Lung and Circulation · doi:10.1016/j.hlc.2021.07.022 · Cited by 31
Self-citationRole of Biological Sex in the Cardiovascular-Gut Microbiome Axis
Li, S., & Kararigas, G. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.759735 · Cited by 29
Short-chain fatty acids: possible regulators of insulin secretion
Rosli, N. S. A., Gani, S. A., Khayat, M. E., Zaidan, U. H., Ismail, A., & Rahim, M. B. H. A. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04528-8 · Cited by 32
Gut Failure: A Review of the Pathophysiology and Therapeutic Potentials in the Gut–Heart Axis
Matsiras, D., Bezati, S., Ventoulis, I., Verras, C., Parissis, J., & Polyzogopoulou, E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072567 · Cited by 35
Wang, A., Li, Q., Sun, Z., Zhang, D., & Ma, X. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109370 · Cited by 30
Li, Y., Ibrahim, R. M. S., Chi, H., Xiao, T., Xia, W., Li, H., & Kang, Y. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000885 · Cited by 29
Gut microbiota: a potential new regulator of hypertension
Ge, Y., Wang, J., Wu, L., & Wu, J. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1333005 · Cited by 32
Cheng, T.-Y., Lee, T., Li, S., Lee, T.-I., Chen, Y., Kao, Y., Higa, S., Chen, P., & Chen, Y.-J. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.08.009 · Cited by 28
Constipation is associated with an increased risk of major adverse cardiac events in a UK population
Zheng, T., Tavares, L. C., D’Amato, M., & Marques, F. Z. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00519.2024 · Cited by 32
Self-citationThe gut–heart axis: a review of gut microbiota, dysbiosis, and cardiovascular disease development
Abdulrahim, A. O., Doddapaneni, N. S. P., Salman, N., Giridharan, A., Thomas, J., Sharma, K., Abboud, E., Rochill, K., Shreelakshmi, B., Gupta, V., et al. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002789 · Cited by 33
Zhou, T., Wang, Z., Lv, X., Guo, M., Zhang, N., Liu, L., Geng, L., Shao, J., Zhang, K., Gao, M., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.01.004 · Cited by 28
Robles‐Vera, I., de la Visitación, N., Toral, M., Sánchez, M., Gómez‐Guzmán, M., Jiménez, R., Romero, M., & Duarte, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111189 · Cited by 29
Fan, H., Zhang, Y., Swallah, M. S., Wang, S., Zhang, J., Fang, J., Lu, J., & Yu, H. (2022) · Foods · doi:10.3390/foods11091298 · Cited by 29
Heaney, L. M. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-0974 · Cited by 30
The Role of Gut Microbiota and Its Metabolites in Patients with Heart Failure
Cienkowski, K., Cienkowska, A., Kupczyńska, K., & Bielecka-Dabrowa, A. M. (2024) · Biomedicines · doi:10.3390/biomedicines12040894 · Cited by 27
Seefeldt, J. M., Homilius, C., Hansen, J., Lassen, T. R., Jespersen, N. R., Jensen, R. V., Boedtkjer, E., Bøtker, H. E., & Nielsen, R. R. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.033744 · Cited by 33
Chen, Y., Zhu, Y., Wu, C.-Y., Lu, A., Deng, M., Yu, H., Huang, C., Wang, W., Li, C., Zhu, Q., et al. (2020) · Nutrition · doi:10.1016/j.nut.2020.110766 · Cited by 27
Tan, H., & Nie, S. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa065 · Cited by 27
Robles‐Vera, I., de la Visitación, N., Toral, M., Sánchez, M., Romero, M., Gómez‐Guzmán, M., Vargas, F., Duarte, J., & Jiménez, R. (2021) · Nutrients · doi:10.3390/nu13092971 · Cited by 27
Ye, X., Tang, X., Li, F., Zhu, J., Wu, M., Wei, X., & Wang, Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.892801 · Cited by 27
Li, N., Wang, L., Li, L., Yang, M.-Z., Wang, Q., Bai, X., Gao, F., Yuan, Y., Yu, Z., & Ren, Z. (2023) · Military Medical Research · doi:10.1186/s40779-023-00489-1 · Cited by 32
Cui, J., Wang, J., & Wang, Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1177768 · Cited by 30
Biomimetic nanocarriers harnessing microbial metabolites usher the path for brain disease therapy
Gong, Y., Liu, Z., Zhou, P., Li, J., & Miao, Y. (2023) · Nano TransMed · doi:10.1016/j.ntm.2023.100020 · Cited by 26
Liu, W., Wang, L., Ou, J., Peng, D., Zhang, Y., Chen, W., & Wang, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083752 · Cited by 36
Zhang, C., Teng, X., Cao, Q., Deng, Y., Yang, M., Wang, L., Rui, D., Xiu, L., Wei, C., Chen, Y., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06821-8 · Cited by 32
Dysbiotic 1‐carbon metabolism in cardiac muscle remodeling
George, A. K., Singh, M., Pushpakumar, S. B., Homme, R. P., Hardin, S. J., & Tyagi, S. C. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29163 · Cited by 26
Rhys-Jones, D. R., Climie, R. E., Jama, H., Gill, P. A., Head, G. A., Gibson, P., Kaye, D. M., Muir, J. G., Mackay, C., & Marques, F. Z. (2021) · Trials · doi:10.1186/s13063-021-05468-2 · Cited by 24
Self-citationThe Bidirectional Signal Communication of Microbiota‐Gut‐Brain Axis in Hypertension
Wang, X., Chen, Z., Geng, B., & Cai, J. (2021) · International Journal of Hypertension · doi:10.1155/2021/8174789 · Cited by 29
Song, Y., Liu, Y., Qi, B., Cui, X., Dong, X., Wang, Y., Han, X., Li, F., Shen, D., Zhang, X., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.119.015292 · Cited by 26
Lacto-Fermented Fruits and Vegetables: Bioactive Components and Effects on Human Health
Wei, L., Beeck, W. V., Hanlon, M., DiCaprio, E. L., & Marco, M. L. (2025) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-052924-070656 · Cited by 25
The gut-heart axis: unveiling the roles of gut microbiota in cardiovascular diseases
Zhang, Y., Wu, H., Jin, M., Feng, G., & Wang, S. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1572948 · Cited by 30
Zhang, L., Ko, C., & Zeng, Y.-M. (2022) · Nature and Science of Sleep · doi:10.2147/nss.s354742 · Cited by 26
Drapkina, O. M., Yafarova, A. A., Kaburova, A. N., & Kiselev, A. R. (2022) · Biomedicines · doi:10.3390/biomedicines10082019 · Cited by 26
Stø, K., Valeur, J., Ueland, T., Malmstrøm, G. H., Bjerkeli, V., Trøseid, M., Hov, J. R., Holm, K., Vestad, B., Halvorsen, B. L., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-26759-x · Cited by 26
Yu, W., Jiang, Y., Xu, H., & Zhou, Y. (2023) · Biomedicines · doi:10.3390/biomedicines11020442 · Cited by 26
Recent Advances in Microbiota-Associated Metabolites in Heart Failure
Masenga, S., Povia, J. P., Lwiindi, P., & Kirabo, A. (2023) · Biomedicines · doi:10.3390/biomedicines11082313 · Cited by 28
Jing, J., Guo, J., Dai, R., Zhu, C., & Zhang, Z. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1252907 · Cited by 28
Zhang, Q., Chen, X., Zhou, S., Lei, Y., Huang, J.-S., Chen, Q., & Cao, H. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1152349 · Cited by 24
Singh, P., Meenatchi, R., Ahmed, Z., Thacharodi, A., Rohinth, M., Kumar, R. R., K, H. V. M., & Hassan, S. (2023) · Medicine in Microecology · doi:10.1016/j.medmic.2023.100096 · Cited by 30
Zhou, G., Jiang, Y., Ma, D., Wang, Y., Jl, Y., Chen, J., Chi, C.-Y., Han, X., Li, Z., & Li, X. (2019) · BioMed Research International · doi:10.1155/2019/9637479 · Cited by 24
Dubiński, P., Czarzasta, K., & Cudnoch‐Jędrzejewska, A. (2021) · Current Hypertension Reports · doi:10.1007/s11906-021-01144-7 · Cited by 27
Yang, Y., Karampoor, S., Mirzaei, R., Бороздкин, Л. Л., & Zhu, P. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110546 · Cited by 24
Moleón, J., González‐Correa, C., Robles‐Vera, I., Miñano, S., de la Visitación, N., Barranco, A. M., Martín‐Morales, N., O’Valle, F., Mayo-Martínez, L., Garcı́a, A., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2247053 · Cited by 26
Maternal Diet and Gut Microbiota Influence Predisposition to Cardiovascular Disease in Offspring
Jama, H. A., Dona, M. S. I., Dinakis, E., Nakai, M. E., Paterson, M. R., Shihata, W., Krstevski, C., Cohen, C. D., Weeks, K. L., Farrugia, G. E., et al. (2024) · Circulation Research · doi:10.1161/circresaha.124.324614 · Cited by 24
Self-citationRole of Gut Microbiota in the Pathogenesis of Cardiovascular Diseases and Metabolic Syndrome
Drapkina, O. M., & Shirobokikh, O. E. (2018) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2018-14-4-567-574 · Cited by 25
Gut Microbiota in Heart Failure—The Role of Inflammation
Fountoulakis, P. N., Theofilis, P., Vlachakis, P. K., Karakasis, P., Pamporis, K., Sagris, Μ., Dimitroglou, Y., Tsioufis, P., Oikonomou, E. K., Tsioufis, K. P., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13040911 · Cited by 26
Relationship between Nutrition and Alcohol Consumption with Blood Pressure: The ESTEBAN Survey
Vallée, A., Gabet, A., Deschamps, V., Blacher, J., & Olié, V. (2019) · Nutrients · doi:10.3390/nu11061433 · Cited by 23
Liu, X., Lai, H., Mi, B., Qi, X., Gan, W., & Du, H. (2020) · Nutrients · doi:10.3390/nu12123814 · Cited by 23
Zhu, Y., Liu, Y., Wu, C.-Y., Li, H., Du, H., Yu, H., Huang, C., Chen, Y., Wang, W., Zhu, Q., et al. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002767 · Cited by 23
Role of Gut Microbiota in Pulmonary Arterial Hypertension
Wu, P., Zhu, T., Tan, Z. Y. A., Chen, S., & Fang, Z. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.812303 · Cited by 23
The Microbial and Metabolic Signatures of Patients with Stable Coronary Artery Disease
Zhong, J., Wu, D., Zeng, Y., Wu, G., Zheng, N., Huang, W., Li, Y., Tao, X., Zhu, W., Sheng, L., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02467-22 · Cited by 24
Muralitharan, R. R., Nakai, M. E., Snelson, M., Zheng, T., Dinakis, E., Xie, L., Jama, H. A., Paterson, M. R., Shihata, W., Wassef, F., et al. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae062 · Cited by 24
Self-citationO’Connor, K. M., Lucking, E. F., Cryan, J. F., & O’Halloran, K. D. (2020) · The Journal of Physiology · doi:10.1113/jp280279 · Cited by 23
Hypertensive Heart Disease: Mechanisms, Diagnosis and Treatment
Huang, X., Hu, L., Long, Z., Wang, X., Wu, J., & Cai, J. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2503093 · Cited by 26
She, J., Sun, L.-Z., Yu, Y., Fan, H., Li, X., Zhang, X., Zhuo, X.-Z., Guo, M., Liu, J.-H., Liu, P., et al. (2024) · Gut microbes · doi:10.1080/19490976.2024.2415487 · Cited by 21
Dietary Lipids, Gut Microbiota, and Their Metabolites: Insights from Recent Studies
Mohammadi, F., & Rudkowska, I. (2025) · Nutrients · doi:10.3390/nu17040639 · Cited by 22
Cross-talk between microbiota–gut–brain axis and blood pressure regulation
Welathanthree, M., Keating, D. J., Macefield, V. G., Carnevale, D., Marques, F. Z., & Muralitharan, R. R. (2025) · Clinical Science · doi:10.1042/cs20240787 · Cited by 24
Self-citationJin, J., Yang, X., Feng, R., Ye, M.-L., Xu, H., Wang, J., Hu, J., Zuo, H., Lu, J., Song, J., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202501579rr · Cited by 24
Li, P., Cai, X., Xiao, N., Ma, X., Zeng, L., Zhang, L., Xie, L., & Du, B. (2020) · Food & Function · doi:10.1039/d0fo01770a · Cited by 23
Wu, C., Chen, Z., Zhang, L., Zhu, Y., Deng, M., Huang, C., Liu, Y., Zhu, Q., & Wang, L. (2020) · Hypertension Research · doi:10.1038/s41440-020-00548-3 · Cited by 22
Olaniyi, K. S., Owolabi, M. N., Atuma, C. L., Agunbiade, T. B., & Alabi, B. Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-98605-5 · Cited by 23
A unique gut microbiota signature in pulmonary arterial hypertension: A pilot study
Jose, A., Apewokin, S. K., Hussein, W. E., Ollberding, N. J., Elwing, J., & Haslam, D. B. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12051 · Cited by 22
Act Locally, Act Globally—Microbiota, Barriers, and Cytokines in Atherosclerosis
Kurilenko, N., Fatkhullina, A. R., Mazitova, A., & Koltsova, E. K. (2021) · Cells · doi:10.3390/cells10020348 · Cited by 22
A review on the effect of gut microbiota on metabolic diseases
Shi, Q., Dai, L., Zhao, Q., & Zhang, X. (2022) · Archives of Microbiology · doi:10.1007/s00203-022-02802-3 · Cited by 23
Gut microbiome and cardiometabolic comorbidities in people living with HIV
Trøseid, M., Nielsen, S. D., & Vujkovic-Cvijin, I. (2024) · Microbiome · doi:10.1186/s40168-024-01815-y · Cited by 25
Role of Gut Microbial Metabolites in Ischemic and Non-Ischemic Heart Failure
Hatamnejad, M. R., Medzikovic, L., Dehghanitafti, A., Rahman, B., Vadgama, A., & Eghbali, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052242 · Cited by 24
Parental diet and offspring health: a role for the gut microbiome via epigenetics
Yang, C., Snelson, M., El‐Osta, A., & Marques, F. Z. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01106-3 · Cited by 22
Self-citationSelf-Balance of Intestinal Flora in Spouses of Patients With Rheumatoid Arthritis
Liu, Z., Wu, Y., Luo, Y., Wei, S., Lu, C., Zhou, Y., Wang, J., Miao, T., Lin, H., Zhao, Y., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00538 · Cited by 24
Ayaz, B. D., Oliveira, A. C. D. S., Malphurs, W. L., Redler, T., de Araujo, A., Sharma, R. K., Sırmagül, B., & Zubcevic, J. A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.690919 · Cited by 21
Chen, K., Nakasone, Y., Yi, S., Ibrahim, H. R., Sakao, K., Hossain, M. A., & Hou, D. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c00555 · Cited by 21
Cui, H., Han, S., Dai, Y., Xie, W., Zheng, R., Sun, Y., Xia, X., Deng, X., Cao, Y., Zhang, M., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154885 · Cited by 23
Taslim, N. A., Yusuf, M. F. R. H., Ambari, A. M., Puling, I. M. D. R., Ibrahim, F. Z., Hardinsyah, H., Kurniawan, R., Gunawan, W. B., Mayulu, N., Joseph, V. F. F., et al. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10105-2 · Cited by 25
Yang, J.-Z., Zhang, K.-K., Shen, H.-W., Liu, Y., Li, X., Chen, L., Liu, J.-L., Li, J.-H., Zhao, D., Wang, Q., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1255971 · Cited by 21
Michael, O. S., Dibia, C., Soetan, O. A., Adeyanju, O. A., Oyewole, A. L., Badmus, O. O., Adetunji, C. O., & Soladoye, A. O. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118127 · Cited by 23
Cante, R. C., Nigro, F., Passannanti, F., Lentini, G., Gallo, M., Nigro, R., & Budelli, A. (2024) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.13356 · Cited by 21
Kidney microbiota dysbiosis contributes to the development of hypertension
Liu, X., Li, J., Zhang, Y., Fan, L., Xia, Y., Wu, Y., Chen, J., Zhao, X., Gao, Q., Xu, B., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2143220 · Cited by 20
Effects of probiotics on hypertension
Yuan, L., Li, Y., Chen, M., Xue, L., Wang, J., Ding, Y., Gu, Q., Zhang, J., Yang, R., Zhao, H., et al. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12369-8 · Cited by 23
Zong, Y., Wang, X., & Wang, J. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1256940 · Cited by 20
Prospects for Leveraging the Microbiota as Medicine for Hypertension
Durgan, D. J., Zubcevic, J. A., Vijay–Kumar, M., Yang, T., Manandhar, I., Aryal, S., Muralitharan, R. R., Li, H., Li, Y., Abais‐Battad, J. M., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.21721 · Cited by 21
Self-citationFurukawa, N., Kobayashi, M., Ito, M., Matsui, H., Ohashi, K., Murohara, T., Takeda, J., Ueyama, J., Hirayama, M., & Ohno, K. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.09.045 · Cited by 20
Lu, C., Sun, T., Li, Y., Zhang, D., Zhou, J., & Su, X. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8601-1 · Cited by 20
Evans, L. W., Athukorala, M., Martinez, K., & Ferguson, B. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114006 · Cited by 22
Pan, S., Zhao, D., Duan, S., & Chen, X. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03500-9 · Cited by 22
Zhao, Z., Jiang, S., Fan, Q., Xu, K., Xu, Y., Wu, F., Zhang, X., Wang, T., & Xia, Z. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1286210 · Cited by 19
Zhou, Z., Sun, L., Zhou, W., Gao, W., Yuan, X., Zhou, H., Ren, Y., Li, B., Wu, Y., & She, J. (2025) · Liver Research · doi:10.1016/j.livres.2025.02.001 · Cited by 19
Aging at the Crossroads of Organ Interactions: Implications for the Heart
Sen, I., Trzaskalski, N. A., Hsiao, Y., Liu, P. P., Shimizu, I., & Dérumeaux, G. (2025) · Circulation Research · doi:10.1161/circresaha.125.325637 · Cited by 20
Causal association between gut microbiota composition and the risk of atrial fibrillation
Tan, J., Wang, J., Yang, Y., Zhu, J., Wang, L., Xu, W., Lyu, S., Wu, S., Wang, J., & Zhang, H. (2025) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2025-0031 · Cited by 19
Self-citationTortelote, G. G. (2025) · Pediatric Nephrology · doi:10.1007/s00467-025-06883-2 · Cited by 23
Zhao, T., Zhang, L., Zhou, N., Sun, D., Xie, J., & Xu, S. (2022) · Food Science & Nutrition · doi:10.1002/fsn3.3069 · Cited by 21
Gut Microbiota and Metabolome Changes in Three Pulmonary Hypertension Rat Models
Luo, L., Yin, H., & Gou, D. (2023) · Microorganisms · doi:10.3390/microorganisms11020472 · Cited by 19
Chemical interplay between gut microbiota and epigenetics: Implications in circadian biology
Sharma, S. A., Oladejo, S. O., & Kuang, Z. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.04.016 · Cited by 19
Jing, L., Li, S., Wang, J., & Zhang, G. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28770 · Cited by 19
Gut Microbiota and Heart, Vascular Injury
Zeng, C., & Tan, H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2385-4_8 · Cited by 19
Dietary Interventions in Heart Failure With Preserved Ejection Fraction
Billingsley, H., Carbone, S., Driggin, E., Kitzman, D. W., & Hummel, S. L. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.101465 · Cited by 18
The impact of lipid metabolism on ferroptosis in myocardial ischemia–reperfusion injury
Li, Y., Lou, Z.-K., Liu, F., Liu, Y., Wang, C., Wang, Y., Qian, W., Li, D., & Xu, T. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02192-z · Cited by 19
Zhang, L., Ko, C., & Zeng, Y. (2022) · Dove Medical Press (Taylor and Francis Group) · Cited by 18
Gut Microbiota and Cardiovascular System: An Intricate Balance of Health and the Diseased State
Bhat, M. A., Mishra, A. K., Tantray, J. A., Alatawi, H. A., Saeed, M., Rahman, S., & Jan, A. T. (2022) · Life · doi:10.3390/life12121986 · Cited by 21
Microbiota‐related metabolites fueling the understanding of ischemic heart disease
Fan, Y., Ying, J., Ma, H., & Cui, H. (2023) · iMeta · doi:10.1002/imt2.94 · Cited by 18
Metadata
- Authors
- Marques, F. Z., Nelson, E., Chu, P.-Y., Horlock, D., Fiedler, A., Ziemann, M., Tan, J. K., Kuruppu, S., Rajapakse, N. W., El-Osta, A., Mackay, C. R., & Kaye, D. M.
- Affiliations
- Baker Heart and Diabetes Institute (AU)
- From Heart Failure Research Group (F.Z.M., E.N., P.-Y.C., D.H., A.F., N.W.R., D.M.K.) and Human Epigenetics Group (M.Z., A.E.-O.), Baker Heart and Diabetes Institute, Melbourne, Australia; Central Clinical School, Faculty of Medicine Nursing and Health Sciences (F.Z.M., A.E.-O., D.M.K.), Infection and Immunity Program, Monash Biomedicine Discovery Institute (J.K.T., C.R.M.), Department of Biochemistry and Molecular Biology (J.K.T., S.K., C.R.M.), and Department of Physiology (N.W.R.), Monash...
- ORCID
- Venue
- Circulation
- Published
- 2017-03-07
- Volume
- 135
- Issue
- 10
- Pages
- 964-977
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2560340862
- Cited by
- 1,065
- References
- 47
- Citations by year
- 2026: 95 · 2025: 142 · 2024: 137 · 2023: 136 · 2022: 148 · 2021: 144 · 2020: 101 · 2019: 77 · 2018: 56 · 2017: 29
- FWCI
- 28.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Own your potential (DEAKIN) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Diabetes Australia Research Trust
- Diabetes Australia
- State Government of Victoria
- Baker Heart and Diabetes Institute
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- high-fiber diet, acetate supplementation, gut microbiota, hypertension, heart failure, mineralocorticoid excess, Bacteroides acidifaciens, Firmicutes/Bacteroidetes ratio, myocardial fibrosis, left ventricular hypertrophy, renal fibrosis, EGR1, circadian rhythm, renin-angiotensin system, MAPK signaling, short-chain fatty acids, cardiovascular disease prevention
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bacteria, Blood Pressure, Dietary Fiber, Disease Models, Animal, Fibrosis, Hypertension, Kidney, Male, Mice, Inbred C57BL, Myocardium, Organ Size, RNA, Ribosomal, 16S, Dietary Supplements, Principal Component Analysis, Gastrointestinal Tract, Mice, Transcriptome, Desoxycorticosterone Acetate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
